Clinical Trial Update: Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing fecal microbiota transplantation for modulating the effects of liver cirrhosis has completed, with results posted in March 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Cristian Ichim | Conditions: Liver Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2026-03-27